Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
103.63
+1.78 (1.75%)
At close: Aug 14, 2026, 4:00 PM EDT
103.58
-0.05 (-0.05%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Spyre Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $123 | Buy | Maintains | $123 | +18.69% | Aug 13, 2026 |
| JonesTrading | JonesTrading | Buy Maintains $104 → $140 | Buy | Maintains | $104 → $140 | +35.10% | Aug 12, 2026 |
| Wedbush | Wedbush | Buy Maintains $130 | Buy | Maintains | $130 | +25.45% | Aug 11, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $128 → $129 | Buy | Maintains | $128 → $129 | +24.48% | Aug 11, 2026 |
| BTIG | BTIG | Buy Reiterates $112 → $132 | Buy | Reiterates | $112 → $132 | +27.38% | Aug 11, 2026 |
| Robert W. Baird | Robert W. Baird | Buy Maintains $90 → $120 | Buy | Maintains | $90 → $120 | +15.80% | Aug 5, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $115 → $130 | Buy | Reiterates | $115 → $130 | +25.45% | Aug 5, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $90 → $115 | Buy | Maintains | $90 → $115 | +10.97% | Aug 5, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.